Jaye Thompson, SVP Clinical Dev & Reg Affairs at Acer Therapeutics, holds 262.35K shares in Greenwich LifeSciences (Ticker: GLSI), holds 4.31K shares in Acer Therapeutics (Ticker: ACER), holds 0.00 shares in Repros (Ticker: ~RPRX). Most recently, Jaye Thompson Bought ― shares of Greenwich LifeSciences on Aug 05, 2024 for an estimated value of 15.15K.
What is the percentage of profitable transactions made by Jaye Thompson?
The percentage of profitable transactions made by Jaye Thompson is 37%.
What is the average return per transaction made by Jaye Thompson?
The average return per transaction made by Jaye Thompson is 2.30%.
What stocks does Jaye Thompson hold?
Jaye Thompson holds: ACER, GLSI, ~RPRX stocks.
What was Jaye Thompson’s latest transaction?
Jaye Thompson latest transaction was an Informative Buy of $15.15K.
What was Jaye Thompson's most profitable transaction?
Jaye Thompson’s most profitable transaction was an Informative Buy of GLSI stock on October 31, 2023. The return on the trade was 77.90%.
What is Jaye Thompson's role in Acer Therapeutics?
Jaye Thompson's role in Acer Therapeutics is SVP Clinical Dev & Reg Affairs.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.